Established in 1978, Biogen is a leading world wide biotechnology company which has pioneered various breakthrough improvements which include a broad portfolio of medicines to treat various sclerosis, the very first permitted therapy for spinal muscular atrophy, two co-created treatment plans to address a defining pathology of Alzheimer’s sicknes